Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

First DePuy ASR Trial Continues

By Stefanie Colella-Walsh on February 22, 2013
Email this postTweet this postLike this postShare this post on LinkedIn

As we previously reported, the first trial in the DePuy ASR hip litigation began in late January 2013, in California. Almost 4 weeks later, the trial continues. Since Johnson & Johnson’s recall of the DePuy ASR in August 2010, approximately 10,000 lawsuits have been filed nationwide.

On February 21, 2013, a toxicologist, Dennis J. Paustenbach testified on behalf of Johnson & Johnson. Specifically, Paustenbach told jurors, “I believe that the cobalt and chromium from the ASR implant did not cause or worsen [the plaintiff’s] systemic health problems.” Paustenbach further testified that the plaintiff’s chromium levels were “of insignificant health risk, basically of no health risk.”

Contrary to Paustenbach’s opinion, the plaintiff’s legal team has argued that the elevated levels of metal in the plaintiff’s body could lead to high blood pressure, high cholesterol, diabetes, stroke and even kidney cancer.

If you have had a hip replacement, which used the DePuy ASR or DePuy Pinnacle devices, you can contact Stark & Stark and speak to one of the Mass Tort attorneys, free of charge, who can help assess any claims that you might have against the DePuy manufacturers.

Photo of Stefanie Colella-Walsh Stefanie Colella-Walsh

Stefanie Colella-Walsh is a Shareholder and member of Stark & Stark’s Litigation, Insurance Coverage & Liability, Intellectual Property and Mass Torts Groups where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation. She is currently involved…

Stefanie Colella-Walsh is a Shareholder and member of Stark & Stark’s Litigation, Insurance Coverage & Liability, Intellectual Property and Mass Torts Groups where she concentrates her practice in complex litigation with a focus in mass tort and pharmaceutical litigation. She is currently involved in representing numerous plaintiffs in federal and state environmental and pharmaceutical mass tort cases, as well as state and federal class action litigations based upon commercial, employment, civil rights, investments/securities and consumer fraud claims. Ms. Colella-Walsh frequently writes about timely legal and legislative developments impacting plaintiffs in mass tort and product liability actions for Stark & Stark’s Mass Tort Law Blog.

Read more about Stefanie Colella-WalshEmail
Show more Show less
  • Posted in:
    Personal Injury
  • Blog:
    Mass Torts Law Blog
  • Organization:
    Stark & Stark

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo